Literature DB >> 15765139

Unchain my heart: the scientific foundations of cardiac repair.

Stefanie Dimmeler1, Andreas M Zeiher, Michael D Schneider.   

Abstract

In humans, the biological limitations to cardiac regenerative growth create both a clinical imperative--to offset cell death in acute ischemic injury and chronic heart failure--and a clinical opportunity; that is, for using cells, genes, and proteins to rescue cardiac muscle cell number or in other ways promote more efficacious cardiac repair. Recent experimental studies and early-phase clinical trials lend credence to the visionary goal of enhancing cardiac repair as an achievable therapeutic target.

Entities:  

Mesh:

Year:  2005        PMID: 15765139      PMCID: PMC1052009          DOI: 10.1172/JCI24283

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  123 in total

1.  Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes.

Authors:  Katsuhisa Matsuura; Toshio Nagai; Nobuhiro Nishigaki; Tomomi Oyama; Junichiro Nishi; Hiroshi Wada; Masanori Sano; Haruhiro Toko; Hiroshi Akazawa; Toshiaki Sato; Haruaki Nakaya; Hiroshi Kasanuki; Issei Komuro
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

Review 2.  Heart induction: embryology to cardiomyocyte regeneration.

Authors:  Ann Foley; Mark Mercola
Journal:  Trends Cardiovasc Med       Date:  2004-04       Impact factor: 6.677

Review 3.  Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.

Authors:  Douglas W Losordo; Stefanie Dimmeler
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

4.  Bioethics and the political distortion of biomedical science.

Authors:  Elizabeth Blackburn
Journal:  N Engl J Med       Date:  2004-03-12       Impact factor: 91.245

5.  Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes.

Authors:  Munira Xaymardan; Lilong Tang; Leze Zagreda; Benedetta Pallante; Jingang Zheng; Joseph L Chazen; Andrew Chin; Inga Duignan; Patrick Nahirney; Shahin Rafii; Takashi Mikawa; Jay M Edelberg
Journal:  Circ Res       Date:  2004-02-12       Impact factor: 17.367

6.  Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation.

Authors:  Jens M Nygren; Stefan Jovinge; Martin Breitbach; Petter Säwén; Wilhelm Röll; Jürgen Hescheler; Jalal Taneera; Bernd K Fleischmann; Sten Eirik W Jacobsen
Journal:  Nat Med       Date:  2004-04-25       Impact factor: 53.440

7.  Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.

Authors:  Arman Askari; Samuel Unzek; Corey K Goldman; Stephen G Ellis; James D Thomas; Paul E DiCorleto; Eric J Topol; Marc S Penn
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

8.  Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells.

Authors:  Judith Haendeler; Jörg Hoffmann; J Florian Diehl; Mariuca Vasa; Ioakim Spyridopoulos; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2004-02-12       Impact factor: 17.367

9.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

10.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.

Authors:  Leora B Balsam; Amy J Wagers; Julie L Christensen; Theo Kofidis; Irving L Weissman; Robert C Robbins
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

View more
  180 in total

1.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.

Authors:  David M Leistner; Ulrich Fischer-Rasokat; Jörg Honold; Florian H Seeger; Volker Schächinger; Ralf Lehmann; Hans Martin; Iris Burck; Carmen Urbich; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

Review 2.  [Interventional, intramyocardial stem cell therapy in ischemic cardiomyopathy: update 2010].

Authors:  M W Bergmann; K Jaquet; C Schneider; K Krause; A Ujeyl; K-H Kuck
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

Review 3.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

4.  The human heart: a self-renewing organ.

Authors:  Jan Kajstura; Toru Hosoda; Claudia Bearzi; Marcello Rota; Silvia Maestroni; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

Review 5.  The paracrine effect: pivotal mechanism in cell-based cardiac repair.

Authors:  Simon Maltais; Jacques P Tremblay; Louis P Perrault; Hung Q Ly
Journal:  J Cardiovasc Transl Res       Date:  2010-06-08       Impact factor: 4.132

Review 6.  Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.

Authors:  Alexander R Lyon; Sian E Harding; Nicholas S Peters
Journal:  J Cardiovasc Transl Res       Date:  2008-07-16       Impact factor: 4.132

Review 7.  Interactome of a cardiopoietic precursor.

Authors:  Randolph S Faustino; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2008-06-03       Impact factor: 4.132

8.  Stem cell therapy trials: a call for standardization.

Authors:  Leslie W Miller
Journal:  J Cardiovasc Transl Res       Date:  2008-07-22       Impact factor: 4.132

9.  ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.

Authors:  Jelena Zlatkovic-Lindor; D Kent Arrell; Satsuki Yamada; Timothy J Nelson; Andre Terzic
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

Review 10.  Cardiogenesis: an embryological perspective.

Authors:  Ramón Muñoz-Chápuli; José M Pérez-Pomares
Journal:  J Cardiovasc Transl Res       Date:  2009-11-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.